VolitionRx Limited (VNRX) Q4 2024 Earnings Call Transcript
VolitionRx Limited (NYSE:VNRX) Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ET Company Participants Louise Batchelor – Chief Marketing & Communications OfficerCameron Reynolds – President & Chief Executive OfficerTerig Hughes – Chief Financial OfficerAndrew Retter – Chief Medical Officer Conference Call Participants Bruce Jackson – The Benchmark CompanyIlya Zubkov – Freedom BrokerSteven Ralston … Read more